Literature DB >> 1616434

Use of a motion sickness history questionnaire for prediction of simulator sickness.

R S Kennedy1, J E Fowlkes, K S Berbaum, M G Lilienthal.   

Abstract

This research assessed the usefulness of the Motion History Questionnaire (MHQ) for the prediction of simulator sickness, a form of motion sickness experienced by pilots training in ground-based flight simulators. Four MHQ scoring keys were compared: (1) the original MHQ key which had been validated on a sample of U.S. Navy student pilots exposed to Coriolis forces, (2 and 3) two keys which had been validated on a sample of civilian college students exposed to simulated ship motions, and (4) a simulator sickness key empirically derived in the present research and cross-validated. Navy and Marine Corps aviators (N = 456) filled out the MHQ prior to their regularly scheduled flight simulator training and were divided into validation and cross-validation samples. All scoring keys were predictive of reported symptoms of sickness, but highest correlations were obtained with the empirically-derived simulator sickness (SS) key. It is suggested that the SS key be used for self-testing so that pilots may be made aware of their risk for developing simulator sickness.

Entities:  

Mesh:

Year:  1992        PMID: 1616434

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  17 in total

1.  A questionnaire for the assessment of the multiple dimensions of motion sickness.

Authors:  P J Gianaros; E R Muth; J T Mordkoff; M E Levine; R M Stern
Journal:  Aviat Space Environ Med       Date:  2001-02

2.  A randomized, crossover, placebo-controlled clinical trial to assess the sensitivity of the CRCDS Mini-Sim to the next-day residual effects of zopiclone.

Authors:  Arthur A Simen; Cynthia Gargano; Jang-Ho Cha; Melissa Drexel; An Bautmans; Ingeborg Heirman; Tine Laethem; Thomas Hochadel; Lien Gheyle; Kim Bleys; Chan Beals; Aubrey Stoch; Gary G Kay; Arie Struyk
Journal:  Ther Adv Drug Saf       Date:  2015-06

3.  Controlling motion sickness and spatial disorientation and enhancing vestibular rehabilitation with a user-worn see-through display.

Authors:  Wesley W O Krueger
Journal:  Laryngoscope       Date:  2011-01       Impact factor: 3.325

4.  Aging: Older Adults' Driving Behavior Using Longitudinal and Lateral Warning Systems.

Authors:  Dustin J Souders; Neil Charness; Nelson A Roque; Hellen Pham
Journal:  Hum Factors       Date:  2019-07-30       Impact factor: 2.888

5.  The viewpoint-specific failure of modern 3D displays in laparoscopic surgery.

Authors:  Shinichiro Sakata; Philip M Grove; Andrew Hill; Marcus O Watson; Andrew R L Stevenson
Journal:  Langenbecks Arch Surg       Date:  2016-08-19       Impact factor: 3.445

6.  Comparison of virtual reality based therapy with customized vestibular physical therapy for the treatment of vestibular disorders.

Authors:  Khalid A Alahmari; Patrick J Sparto; Gregory F Marchetti; Mark S Redfern; Joseph M Furman; Susan L Whitney
Journal:  IEEE Trans Neural Syst Rehabil Eng       Date:  2014-03       Impact factor: 3.802

7. 

Authors:  Francisco Ríos Tejada
Journal:  FMC       Date:  2009-01-06

Review 8.  Virtual-Reality Performance-Based Assessment of Cognitive Functions in Adult Patients With Acquired Brain Injury: A Scoping Review.

Authors:  Claudia Corti; Maria Chiara Oprandi; Mathilde Chevignard; Ashok Jansari; Viola Oldrati; Elisabetta Ferrari; Monica Martignoni; Romina Romaniello; Sandra Strazzer; Alessandra Bardoni
Journal:  Neuropsychol Rev       Date:  2021-04-30       Impact factor: 7.444

9.  A survey of visually induced symptoms and associated factors in spectators of three dimensional stereoscopic movies.

Authors:  Angelo G Solimini; Alice Mannocci; Domitilla Di Thiene; Giuseppe La Torre
Journal:  BMC Public Health       Date:  2012-09-13       Impact factor: 3.295

10.  Motion sickness: more than nausea and vomiting.

Authors:  James R Lackner
Journal:  Exp Brain Res       Date:  2014-06-25       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.